 (Thorax 1995;50:635-638) 
ever, the ability to compare the prevalence of rates of asthma between different areas -for example, rural versus urban communitiesand longitudinally requires the equipment and protocols used to measure airways reactivity to be well standardised.
An essential component of standardisation is ensuring that the dose of provoking agent generated by the aerosol delivery system is measured accurately and is reproducible. This is traditionally calculated from the weight loss per actuation."q It has been shown, however, that weight loss significantly overestimates the solute output of a number of different jet nebulisers, due mainly to concomitant evaporative water loss. [5] [6] [7] There are a number of different aerosol delivery systems available. The Yan et 
MEASUREMENT OF AEROSOL OUTPUT BY WEIGHT LOSS
Sodium chloride (0 9%), 1 ml or 3 ml, was placed in each of the DeVilbiss 40 and 45 nebulisers respectively. These volumes were used to ensure that the inlet tubes of each nebuliser type were covered. The vent holes were stoppered and the units weighed on a Mettler analytical balance to the nearest 0 01 mg. After removing the stoppers the bulb of each nebuliser was squeezed firmly 10 times. The stoppers were then replaced and the unit re-weighed. Weight loss per actuation was used to calculate aerosol output.
MEASUREMENT OF AEROSOL OUTPUT BY FLUORIDE TRACER TECHNIQUE
The principle of this technique for measuring the true solute output from nebulisers has been described in more detail elsewhere.' Briefly, 1 ml or 3 ml of a 1% w/v sodium fluoride solution were placed in the appropriate nebulisers. The tip of the throat tube was placed just inside a 5 cm long plastic tube with an internal diameter of 3-7 cm which was used to represent their in vivo operating conditions. Each nebuliser was actuated 10 times and the generated aerosol per actuation entrained onto a 25 mm Whatman glass fibre filter (GF/A) paper held within an open faced filter holder (Nalgene 335-4000) at the end of the plastic tube through which air was being drawn by a vacuum pump at 24 1/min. The filter paper was then removed and the fluoride desorbed overnight by soaking in an appropriate buffer. The quantity of fluoride collected on each filter paper was measured electrochemically and the true solute output per actuation calculated.
The study was approved by the Alfred Hospital ethical committee and all patients gave written informed consent to participate.
MEASUREMENT OF AIRWAYS RESPONSIVENESS
The protocol of Yan et al8 was strictly followed. Spirometric parameters were measured with a calibrated Fleisch pneumotachograph (lung function analyser; Hewlett-Packard). Baseline spirometric values (forced expiratory volume in one second (FEV1) and forced vital capacity (FVC)) were measured and repeated until the values of FEV1 and FVC were reproducible to within 100 ml. Nebuliser sets were primed with saline, 6&25 mg/ml, 25 mg/ml, and 50 mg/ml histamine solutions. Inhalations were administered by placing the tip of the nebuliser throat tube just inside the open mouth and compressing the bulb at the beginning of maximal inspiration having started from slightly below functional residual capacity. Doubling doses of histamine were administered to subjects using 1-4 puffs within three minutes of the previous dose and spirometric tests were performed 30-60 seconds later. Table 2 shows the mean airways responsiveness measurements calculated as PD20 and dose-response slopes to histamine using both the DeVilbiss 40 and 45 nebulisers. The geometric mean PD20 value using the DeVilbiss 40 nebuliser system was a significant 1-7 doubling doses of histamine higher than with the DeVilbiss 45 nebulisers. In one patient the PD20 measured by both nebuliser systems was identical but in the remaining 12 patients the PD20 values were all higher using the DeVilbiss 40 than with the DeVilbiss 45 nebulisers and occurred across the wide range of airways hyperresponsiveness measured ( figure) .
The dose-response slopes were also significantly different between the two nebuliser types, being higher with the DeVilbiss 45 as might be expected from the above results. Geometric mean PD20 obtained with DV4ONs and DV45Ns (jg) Calibration by weight loss was performed in the standard way by weighing the nebuliser units before and after actuation into the room. However, these are not the precise conditions under which nebulisers are operated during airways responsiveness testing. The fluoride tracer technique more closely resembles this situation, with the vacuum pump representing a patient inspiring during nebuliser actuation. In this more realistic setting weight loss is increased by an average of 18% (personal observation) and the aerosol fraction would consequently be even further reduced.
Of perhaps more concern is the fact that the results of the present study suggest that the calibration of nebulisers by weight loss may actually be misleading. We have shown that although weight loss per actuation was not significantly different between the two types of DeVilbiss nebuliser, the DeVilbiss 45 generated almost twice as much active drug as the DeVilbiss 40. This has important implications if it is assumed that the outputs, based on weight loss, are similar: (a) if the two nebuliser types are then used interchangeably for airway responsiveness measurements, and (b) if comparisons of different studies using the two different types ofnebuliser are performed without taking this into account.
Having established that the aerosol outputs of the two types of DeVilbiss nebulisers were significantly different, the clinical part of the study was performed to determine if this was translated into a clinically significant difference in PD20 measurements. We have shown this to be the case with PD20 measurements being consistently higher with the DeVilbiss 40 nebulisers by a mean 1-7 doubling doses of histamine compared with the DeVilbiss 45 nebulisers. This difference is greater than we would expect based on the demonstrated output differences and probably reflects other differences in the performance characteristics o of these two nebulisers -for example, droplet size. Certainly it has been reported that less than half of the output of the DeVilbiss 40 nebuliser is of a respirable size (less than 6 For research purposes weight loss per actuation is therefore an inappropriate measure of nebuliser output and we would recommend the use of the fluoride tracer technique for this purpose. DeVilbiss 40 and 45 nebulisers should not be used interchangeably for testing airways responsiveness and caution is needed when comparing airways responsiveness rates and severity between studies which have employed these two different DeVilbiss hand held nebulisers. It will be important in future studies to specify which DeVilbiss nebuliser is being used for airways responsiveness testing. 
